BioVex's Series F - II Round

BioVex raised a round of funding on November 23, 2009.

BioVex is a biotechnology company that develops vaccines. The company develops vaccines for the treatment of cancer and chronic infectious diseases. BioVex has two proprietary vaccine platforms; OncoV…

Articles about BioVex's Series F - II Round: